BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Clinical trial NCT06414434 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06414434
Sponsor: Michael Wagner, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Liposarcoma Recurrent Liposarcoma Metastatic Liposarcoma Unresectable Liposarcoma MDM2 Gene Amplification Myxoid Liposarcoma CIC-Rearranged Sarcoma

Start date: 2024-09-30
Primary completion: 2027-01-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.